Back |
home / stock / xers / xers message board
Subject | By | Source | When |
---|---|---|---|
Loading here. Great day today. Looking good for | AW104 | investorshub | 07/27/2020 9:11:21 PM |
Gm $Xers Loading up some more. | Gabester | investorshub | 07/06/2020 4:38:26 PM |
I am loaded to the gills | logsplitter | investorshub | 07/06/2020 4:01:39 PM |
We gonna pound the shorts | logsplitter | investorshub | 07/05/2020 9:10:45 PM |
Very soon I see $4-$6 | Gabester | investorshub | 07/05/2020 7:38:59 PM |
Yes it will | Gabester | investorshub | 07/03/2020 7:27:48 PM |
Will be in next week! Happy 4th. | Jellyfish | investorshub | 07/02/2020 3:27:16 PM |
She gonna fly soon | logsplitter | investorshub | 07/02/2020 3:25:58 PM |
Do you think we are ready here crude? $XERS | Golden Cross | investorshub | 07/02/2020 12:51:20 PM |
On June 30, 2020, Xeris Pharmaceuticals, Inc. (the | crudeoil24 | investorshub | 07/02/2020 11:38:51 AM |
Xeris Pharmaceuticals (NASDAQ:$XERS) Cut to Hold at Zacks | Golden Cross | investorshub | 06/27/2020 4:17:34 AM |
Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing | Golden Cross | investorshub | 06/27/2020 4:16:47 AM |
News, Short Squeeze, Breakout and More Instantly...
Xeris Pharmaceuticals Inc. Company Name:
XERS Stock Symbol:
NASDAQ Market:
John Shannon, President and Chief Operating Officer, to succeed Paul Edick as new CEO and Board Director Transition timing aligns with the solid financial position of the Company, including consistently strong growth from its commercial franchise, healthy cash position, and the track reco...
Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies, today announced that on July 1, 2024, the Compensation Committee of Xeris’ Boar...
In patients with Cushing’s syndrome maintained on Recorlev, a lower baseline mUFC was associated with higher cortisol normalization rate. Lower mUFC at baseline was also associated with lower maintenance dose requirements and lower rates of potentially clinically important liver-re...